We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Consensus Estimate for IQV’s earnings for the soon-to-be-reported quarter has been revised upward by 4.6% year over year to $2.76 per share. Meanwhile, the Zacks Consensus Estimate for revenues is pegged at $3.96 billion, which indicates a rise of 3.8% year over year.
IQV has a decent earnings surprise history, having surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 1.7%.
Research and Development Solutions (“R&DS”) revenues are expected to be $2.2 billion, hinting at a 2% rise from the year-ago reported figure. The continued growth of R&DS forward-looking indicators, such as qualified pipeline, RFP flow and backlog, is expected to have fueled this segment’s revenue growth.
Our estimate for revenues from Technology and Analytics Solutions is pegged at $1.58 billion, indicating a 5.5% rise on a year-over-year basis. Robust demand for integrated solutions that combine information, analytics and services is likely to have improved the segment’s revenues.
Our estimate for Contract Sales and Medical solutions’ revenues is pegged at $181.9 million, implying 5.8% growth from the year-ago quarter’s actual.
Our estimate for the first quarter’s adjusted EBITDA is pegged at $899.4 million, suggesting 1.4% year-over-year growth. A strong top line and price discipline are expected to have driven the bottom line.
What Our Model Says About IQV
Our proven model does not conclusively predict an earnings beat for IQVIA this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Here are a few stocks from the broader Business Services sector, which, according to our model, have the right combination of elements to beat on earnings this season:
Veralto Corporation (VLTO - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter 2025 revenues is pegged at $1.34 billion, indicating a 4.3% rise year over year. For earnings, the consensus mark is pegged at 89 cents per share, suggesting a 4.7% increase from the year-ago quarter’s reported figure. The company beat the consensus estimate in each of the past four quarters, with an average surprise of 6.4%. (See Zacks Earnings Calendar to stay ahead of market-making news.)
VLTO currently has an Earnings ESP of +1.55% and a Zacks Rank of 2.
Equifax (EFX - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter 2025 revenues is pegged at $1.5 billion, implying a 5.9% rise year over year. For earnings, the consensus mark is pegged at $1.92 per share, suggesting a 5.5% increase from the year-ago quarter’s reported figure. The company beat the consensus estimate in each of the past four quarters, with an average surprise of 4.2%.
EFX currently has an Earnings ESP of +1.46% and a Zacks Rank of 3.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IQVIA Gears Up to Report Q2 Earnings: What's in Store for the Stock?
Key Takeaways
IQVIA Holdings Inc. (IQV - Free Report) will release its second-quarter 2025 results on July 22, before market open.
The Zacks Consensus Estimate for IQV’s earnings for the soon-to-be-reported quarter has been revised upward by 4.6% year over year to $2.76 per share. Meanwhile, the Zacks Consensus Estimate for revenues is pegged at $3.96 billion, which indicates a rise of 3.8% year over year.
IQV has a decent earnings surprise history, having surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 1.7%.
IQVIA Holdings Inc. Price and EPS Surprise
IQVIA Holdings Inc. price-eps-surprise | IQVIA Holdings Inc. Quote
IQVIA’s Q2 Expectations
Research and Development Solutions (“R&DS”) revenues are expected to be $2.2 billion, hinting at a 2% rise from the year-ago reported figure. The continued growth of R&DS forward-looking indicators, such as qualified pipeline, RFP flow and backlog, is expected to have fueled this segment’s revenue growth.
Our estimate for revenues from Technology and Analytics Solutions is pegged at $1.58 billion, indicating a 5.5% rise on a year-over-year basis. Robust demand for integrated solutions that combine information, analytics and services is likely to have improved the segment’s revenues.
Our estimate for Contract Sales and Medical solutions’ revenues is pegged at $181.9 million, implying 5.8% growth from the year-ago quarter’s actual.
Our estimate for the first quarter’s adjusted EBITDA is pegged at $899.4 million, suggesting 1.4% year-over-year growth. A strong top line and price discipline are expected to have driven the bottom line.
What Our Model Says About IQV
Our proven model does not conclusively predict an earnings beat for IQVIA this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
IQV has an Earnings ESP of -0.26% and a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Here are a few stocks from the broader Business Services sector, which, according to our model, have the right combination of elements to beat on earnings this season:
Veralto Corporation (VLTO - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter 2025 revenues is pegged at $1.34 billion, indicating a 4.3% rise year over year. For earnings, the consensus mark is pegged at 89 cents per share, suggesting a 4.7% increase from the year-ago quarter’s reported figure. The company beat the consensus estimate in each of the past four quarters, with an average surprise of 6.4%. (See Zacks Earnings Calendar to stay ahead of market-making news.)
VLTO currently has an Earnings ESP of +1.55% and a Zacks Rank of 2.
Equifax (EFX - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter 2025 revenues is pegged at $1.5 billion, implying a 5.9% rise year over year. For earnings, the consensus mark is pegged at $1.92 per share, suggesting a 5.5% increase from the year-ago quarter’s reported figure. The company beat the consensus estimate in each of the past four quarters, with an average surprise of 4.2%.
EFX currently has an Earnings ESP of +1.46% and a Zacks Rank of 3.